Results 141 to 150 of about 71,840 (355)
Ménière's Disease: A Tri‐Decade Scoping Review of Treatment Trends and Evidence Quality
This tri‐decade scoping review of Ménière's disease literature reveals a significant increase in high‐level evidence and a clinical pivot toward hearing‐preserving interventions, such as intratympanic steroids and cochlear implants. However, a significant quality paradox has emerged, where adherence to standardized AAO‐HNS reporting and diagnostic ...
Ofir Zavdy +4 more
wiley +1 more source
TITLE: SALVAGING COCHLEAR IMPLANT AFTER SUSPECTED BIOFILM INFECTION- Our experience [PDF]
Neeraj Suri +2 more
openalex +1 more source
Dicrananthera C. Presl. is a monospecific genus of the tribe Marcetieae, comprising perennial herbs typically occurring in areas adjacent to wetlands. The species exhibits a disjunct distribution, with confirmed records in both the Amazon and Atlantic Forest domains.
Elias Julio Oliveira Correa +4 more
wiley +1 more source
Abstract Objective Personalized medicine in cochlear implantation has advanced significantly with the advent of software tools that allow for detailed analysis of cochlear anatomy. This facilitates the selection of electrode arrays tailored to the individual cochlear duct length (CDL) and supports anatomy‐based fitting strategies. Concurrently, various
Tobias Rader +4 more
wiley +1 more source
Across-Frequency Temporal Processing and Speech Perception in Cochlear Implant Recipients and Normal Hearing Listeners [PDF]
Chelsea M. Blankenship +2 more
openalex +1 more source
Abstract MYO7A is a causal gene, underlying Usher syndrome type 1B (USH1B) and both autosomal recessive (DFNB2) and dominant (DFNA11) non‐syndromic hearing loss. Despite the large number of reported MYO7A variants (over 2,200), variants located in an extended splice region remain difficult to interpret and are often classified as variants of uncertain ...
Tao Shi +5 more
wiley +1 more source
“Can you hear me now?”: Insurance Coverage for Hearing Benefits in the United States [PDF]
Public and private insurance coverage for hearing benefits underscores the gaps in coverage for treating hearing loss in the U.S. The commodification of the hearing benefits sector of healthcare in this country has detrimental consequences for personal ...
Whipple, Reegan
core +1 more source
Jervell and Lange‐Nielsen Syndrome Related Clinical Genetics and Experimental Models
ABSTRACT Jervell and Lange‐Nielsen syndrome (JLNS) is defined by electrocardiographic QT prolongation and sensorineural hearing loss, caused by homozygous or compound heterozygous variants in KCNQ1 and/or KCNE1. KCNQ1 encodes the alpha subunit Kv7.1 of the ion channels accountable for slow delayed rectifier potassium currents (IKs), whereas KCNE1 ...
Yafei Zhou +3 more
wiley +1 more source
Noise‐Induced Hearing Loss: From Pathological Mechanisms to Therapeutic Interventions
ABSTRACT Noise‐induced hearing loss (NIHL), a significant non‐genetic form of hearing impairment, is primarily managed through the use of hearing aids and cochlear implants. However, the fundamental pathological mechanisms underlying NIHL remain inadequately addressed.
Shiqi Huang +7 more
wiley +1 more source
Cochlear implants are a well-established solution for restoring hearing in severe impairment and profound deafness. However, cochlear implants still have limitations, such as speech recognition in noisy environments caused by intra-cochlear current ...
Merle Sehlmeyer +8 more
doaj +1 more source

